Do You Believe West Pharmaceutical Services (WST) Represents a Tremendous Opportunity?
Generation Investment Management, an investment management firm, released its “Global Equity Strategy” second quarter 2026 investor letter.
Posts Tagged ‘NYSE:WST’
Broad-Based Growth Lifted West Pharmaceuticals (WST) in Q2
Conestoga Capital Advisors, an asset management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here.
10 Most Profitable Dividend Stocks to Invest In Now
In this article, we will take a look at the 10 Most Profitable Dividend Stocks to Invest In Now.
10 Best Stocks to Buy According to Billionaire Bill Gates
In this article, we will discuss the 10 Best Stocks to Buy According to Billionaire Bill Gates.
West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2026 Earnings Call Transcript
West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2026 Earnings Call Transcript April 23, 2026West Pharmaceutical Services, Inc. beats earnings expectations.
Is West Pharmaceutical Services, Inc. (WST) A Good Stock To Buy Now?
Is WST a good stock to buy? We came across a bullish thesis on West Pharmaceutical Services, Inc. on MaxDividends’s Substack.
Dividend Kings and Aristocrats List: 32 Biggest Stocks
In this article, we will take a look at the Dividend Kings and Aristocrats List: 32 Biggest Stocks.
Here is Why West Pharmaceutical Services, Inc. (WST) is Strongly Favored by Hedge Funds
West Pharmaceutical Services, Inc. (NYSE:WST) is one of the 10 best life sciences stocks to buy according to hedge funds.
10 Best Life Sciences Stocks to Buy According to Hedge Funds
Following a difficult start in 2025, the ever-evolving life sciences segment recovered strongly in the latter half of the year.
BofA Cuts West Pharmaceutical (WST) Target Following Model Update and Sector Pressure
West Pharmaceutical Services, Inc. (NYSE:WST) is included among the 13 Best Strong Buy Dividend Stocks to Invest in.
13 Best Strong Buy Dividend Stocks to Invest In
In this article, we will take a look at the 13 Best Strong Buy Dividend Stocks to Invest In.
West Pharmaceutical Services (WST) is Returning to Sustainable Volume Growth
Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2025 Earnings Call Transcript
West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2025 Earnings Call Transcript February 12, 2026West Pharmaceutical Services, Inc. misses on earnings expectations.
West Pharmaceutical Services, Inc. (WST): A Bull Case Theory
We came across a bullish thesis on West Pharmaceutical Services, Inc. on TipRanks™’s YouTube Channel. In this article, we will summarize the bulls’ thesis on WST.
Upslope Capital Management Exited West Pharmaceutical (WST) for Better Opportunities
Upslope Capital Management, an investment management company, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
KeyBanc Sees Injectable GLP-1s Driving Ongoing Demand for WST
West Pharmaceutical Services, Inc. (NYSE:WST) is included among the 14 Best Dividend Growth Stocks to Buy and Hold in 2026.
14 Best Dividend Growth Stocks to Buy and Hold in 2026
In this article, we will take a look at some of the best dividend aristocrat stocks to invest in. Dividends play a real role in equity returns.
West Pharmaceutical Services (WST) Rebounded in Q3
Brown Advisory, an investment management company, released its “Brown Advisory Large-Cap Growth Strategy” third-quarter 2025 investor letter.
9 Stocks in Bill Gates’ Portfolio That Analysts are Watching
In this article, we will take a look at the 10 Stocks in Bill Gates' Portfolio That Analysts are Watching.
TD Cowen Initiates Coverage on West Pharmaceutical (WST) with Buy Rating and $350 Target
West Pharmaceutical Services, Inc. (NYSE:WST) is included among the 13 Best Consistent Dividend Stocks to Buy Now.
West Pharmaceutical Services, Inc. (NYSE:WST) Q3 2025 Earnings Call Transcript
West Pharmaceutical Services, Inc. (NYSE:WST) Q3 2025 Earnings Call Transcript October 23, 2025West Pharmaceutical Services, Inc. beats earnings expectations.
What Makes West Pharmaceutical Services (WST) a Prospective Investment?
Upslope Capital Management, an investment management company, released its third-quarter investor letter. A copy of the letter can be downloaded here.
Improved Investor Confidence Boosted West Pharmaceutical Services (WST)
Conestoga Capital Advisors, an asset management company, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Should You Be Optimistic on West Pharmaceutical (WST)?
Brown Advisory, an investment management company, released its “Brown Advisory Large-Cap Growth Strategy” second-quarter 2025 investor letter.
West Pharmaceutical Services, Inc. (NYSE:WST) Q2 2025 Earnings Call Transcript
West Pharmaceutical Services, Inc. (NYSE:WST) Q2 2025 Earnings Call Transcript July 24, 2025West Pharmaceutical Services, Inc. beats earnings expectations.
Barclays Cautious on West Pharma (WST) on Non-Core Weakness and Injectable Disruption Risks
West Pharmaceutical Services Inc. (NYSE:WST) is one of the most oversold S&P 500 stocks so far in 2025.
10 Most Oversold S&P 500 Stocks So Far in 2025
The S&P 500 Index has delivered a strong performance in 2025 as it has climbed over 7% and reached new all-time highs.
West Pharmaceutical Services, Inc. (WST): A Bull Case Theory
We came across a bullish thesis on West Pharmaceutical Services, Inc. on R. Dennis’s Substack by OppCost. In this article, we will summarize the bulls’ thesis on WST.
Is West Pharmaceutical Services (WST) a Great Business Unfairly Sold Off by the Market?
Brasada Capital Management, an investment management company, released its Q2 2025 investor letter. A copy of the letter can be downloaded here.
West Pharmaceutical Services (WST) Fell on Lowered Guidance
Parnassus Investments, an investment management company, released the “Parnassus Mid Cap Growth Fund” first quarter 2025 investor letter.
Should You Hold West Pharmaceutical Services (WST)?
Baron Funds, an investment management company, released its “Baron Asset Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
West Pharmaceutical Services, Inc. (WST): A Bull Case Theory
We came across a bullish thesis on West Pharmaceutical Services, Inc. (WST) on Swiss Transparent Portfolio’s Substack.
West Pharmaceutical Services, Inc. (WST): A Bull Case Theory
We came across a bullish thesis on West Pharmaceutical Services, Inc. (WST) on Business Model Mastery’s Substack.
West Pharmaceutical Services (WST) Fell on Disappointing Guidance
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Here’s Why West Pharmaceutical Services (WST) Stock Fell 38%
Conestoga Capital Advisors, an asset management company, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here.
11 Worst Performing Stocks in S&P 500 So Far in 2025
This article looks at the 11 worst performing stocks in the S&P 500 so far in 2025.
West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2025 Earnings Call Transcript
West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2025 Earnings Call Transcript April 24, 2025West Pharmaceutical Services, Inc. beats earnings expectations.
15 Low Profile Dividend Champions to Buy
In this article, we will take a look at some of the best Dividend Champions to buy.
Why These 15 Large-Cap Stocks Are Plunging So Far In 2025
The big and large-cap stocks have spearheaded the rally in the past two years, but Wall Street’s expectations have gotten ahead of many of their fundamentals.
West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2024 Earnings Call Transcript
West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2024 Earnings Call Transcript February 13, 2025West Pharmaceutical Services, Inc. beats earnings expectations.
West Pharmaceutical Services (WST) Bounced Back in Q4
Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Should You Sell Your Holdings in West Pharmaceutical Services (WST)?
ClearBridge Investments, an investment management company, released its “ClearBridge Mid Cap Growth Strategy” third quarter 2024 investor letter.
10 Worst Performing Healthcare Stocks in 2024
In this article, we will be taking a look at the 10 worst performing healthcare stocks in 2024.
UBS’ Bottom Quant Stocks In AI, IT, Healthcare & Others: 29 Stocks In All Sectors
In this piece, we will take a look at the lowest-scoring stocks in earnings revisions, P/E ratios, EPS growth, and other indicators according to investment bank UBS.
West Pharmaceutical Services (WST) Fell Due to Lower-Than-Expected Results and Reduced Guidance
Baron Funds, an investment management company, released its “Baron Asset Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
West Pharmaceutical Services, Inc. (NYSE:WST) Q3 2024 Earnings Call Transcript
West Pharmaceutical Services, Inc. (NYSE:WST) Q3 2024 Earnings Call Transcript October 24, 2024West Pharmaceutical Services, Inc. beats earnings expectations.
West Pharmaceuticals (WST) Fell Due to Industry Headwinds
Conestoga Capital Advisors, an asset management company, released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Should You Hold West Pharmaceutical Services (WST) for the Long Term?
Conestoga Capital Advisors, an asset management company, released its “Mid-Cap Strategy” second-quarter 2024 investor letter. A copy of the letter can be downloaded here.
West Pharmaceutical Services, Inc. (NYSE:WST) Q2 2024 Earnings Call Transcript
West Pharmaceutical Services, Inc. (NYSE:WST) Q2 2024 Earnings Call Transcript July 25, 2024West Pharmaceutical Services, Inc. misses on earnings expectations.
Does West Pharmaceutical Services (WST) Have Attractive Growth Drivers?
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Hedge Fund Resource Center
